Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Dow
Harvard Business School
Julphar
Merck
Accenture
Medtronic
McKesson
Teva

Generated: May 21, 2018

DrugPatentWatch Database Preview

Lab Hra Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for LAB HRA PHARMA, and what generic alternatives to LAB HRA PHARMA drugs are available?

LAB HRA PHARMA has one approved drug.

There are five US patents protecting LAB HRA PHARMA drugs.

There are fifty-three patent family members on LAB HRA PHARMA drugs in twenty-seven countries.

Summary for Lab Hra Pharma
International Patents:53
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Lab Hra Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 9,283,233 ➤ Try a Free Trial ➤ Try a Free Trial
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 8,426,392 ➤ Try a Free Trial ➤ Try a Free Trial
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 8,735,380 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 8,962,603 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for LAB HRA PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 30 mg ➤ Subscribe 2014-08-13

Non-Orange Book US Patents for Lab Hra Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,073 Method for on-demand contraception ➤ Try a Free Trial
9,844,510 Ulipristal acetate tablets ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Farmers Insurance
Chinese Patent Office
Harvard Business School
Daiichi Sankyo
Boehringer Ingelheim
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.